Surgery is associated with better long-term outcomes than pharmacological treatment for obesity: a systematic review and meta-analysis
Open accessThe DOI matches its Crossref record; 61 of the 62 references it cites were found in a registry or an index.
Abstract
Obesity is a highly prevalent disease with numerous complications. Both intensive medical treatment with the use of pharmacological drugs and bariatric surgery are current options. The objective of this meta-analysis was to compare, in the long-term, intensive medical treatment and surgery based on twelve parameters related to weight loss, cardiovascular and endocrine changes. A review of the literature was conducted in accordance with the PRISMA guidelines (PROSPERO: CRD42021265637). The literature screening was done from inception to October 2023 through PubMed, EMBASE and Web of Science databases. We included randomized clinical trials that had separate groups for medical treatment and bariatric surgery as an intervention for obesity. The risk of bias was assessed through RoB2. A meta-analysis was performed with measures of heterogeneity and publication bias. Subgroup analysis for each surgery type was performed. Data is presented as forest-plots. Reviewers independently identified 6719 articles and 6 papers with a total 427 patients were included. All studies were randomized controlled trials, three had a follow up of 5 years and two had a follow up of 10 years. Both groups demonstrated statistical significance for most parameters studied. Surgery was superior for weight loss (− 22.05 kg [− 28.86; − 15.23), total cholesterol (− 0.88 [− 1.59; − 0.17]), triglycerides (− 0.70 [− 0.82; − 0.59]), HDL (0.12 [0.02; 0.23]), systolic pressure (− 4.49 [− 7.65; − 1.33]), diastolic pressure (− 2.28 [− 4.25; − 0.31]), Hb glycated (− 0.97 [− 1.31; − 0.62]), HOMA IR (− 2.94; [− 3.52; − 2.35]) and cardiovascular risk (− 0.08; [− 0.10; − 0.05]). Patient in the surgical treatment group had better long term outcomes when compared to the non-surgical group for most clinical parameters.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Bariatric surgery is a highly effective treatment for obesity, often leading to more pronounced and sustained weight loss than GLP-1 RAs (mean difference: −22.7 kg, 95% CI −31.4, −14.0)16 and pharmalogical treatment as a whole (−22.1 kg, 95% CI −28.9, −15.2).17”
From The expanding role of GLP-1 receptor agonists: a narrative review of current evidence and future directions (2025) · cites this paper as [17]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PRISMA-P Group, Moher, D., Shamseer, L., Clarke, M., Ghersi, D., Liberati, A., Petticrew, M., Shekelle, P., & Stewart, L. A. (2015) · Systematic Reviews · doi:10.1186/2046-4053-4-1 · Cited by 26,223 · cited 1×
“This systematic review was carried out in accordance with the items of Preferred Reports for Systematic Reviews and Protocol Meta-Analysis (PRISMA-P) 10 and assessing the methodological quality of systematic reviews (AMSTAR-2) guidelines 11 .”
MethodRayyan-a web and mobile app for systematic reviews.
Ouzzani, M., Hammady, H., Fedorowicz, Z., & Elmagarmid, A. (2016) · Systematic Reviews · doi:10.1186/s13643-016-0384-4 · Cited by 26,092 · cited 1×
“The risk of bias for intervention-type studies was analyzed using the guidelines of the Cochrane Back Review Group (CBRG) 14 .”
MethodReduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
Shea, B. J., Reeves, B. C., Wells, G., Thuku, M., Hamel, C., Moran, J., Moher, D., Tugwell, P., Welch, V., Kristjansson, E., et al. (2017) · BMJ · doi:10.1136/bmj.j4008 · Cited by 10,636
Health effects of overweight and obesity in 195 countries over 25 years
Collaborators, T. G. 2. O. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1614362 · Cited by 7,918
Mechanisms linking obesity to insulin resistance and type 2 diabetes
Kahn, S. E., Hull, R. L., & Utzschneider, K. M. (2006) · Nature · doi:10.1038/nature05482 · Cited by 5,448
Prospective Studies Collaboration (2009) · The Lancet · doi:10.1016/s0140-6736(09)60318-4 · Cited by 4,807
Bariatric Surgery versus Intensive Medical Therapy for Diabetes — 5-Year Outcomes
Schauer, P. R., Bhatt, D. L., Kirwan, J. P., Wolski, K., Aminian, A., Brethauer, S. A., Navaneethan, S. D., Singh, R. P., Pothier, C. E., Nissen, S. E., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1600869 · Cited by 2,934 · cited 7×
“Three studies had data on cholesterol 17,19,20 .”
BackgroundMethodInfluentialChooi, Y. C., Ding, C., & Magkos, F. (2019) · Metabolism · doi:10.1016/j.metabol.2018.09.005 · Cited by 2,737 · cited 1×
“In addition, many articles do not adequately describe the strategy used in non-surgical treatment.”
BackgroundA Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management
Pi-Sunyer, X., Astrup, A., Fujioka, K., Greenway, F., Halpern, A., Krempf, M., Lau, D. C. W., le Roux, C. W., Violante Ortiz, R., Jensen, C. B., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1411892 · Cited by 2,724 · cited 1×
“Finally, choosing the most appropriate treatment often involves individual characteristics of each patient, and the impact on quality of life can be extremely subjective and difficult to assess.”
BackgroundGastrointestinal Surgery for Severe Obesity
Panel, C. D. C. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-115-12-956 · Cited by 2,163 · cited 1×
“Finally, choosing the most appropriate treatment often involves individual characteristics of each patient, and the impact on quality of life can be extremely subjective and difficult to assess.”
BackgroundTirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes
Frías, J. P., Davies, M. J., Rosenstock, J., Pérez Manghi, F. C., Fernández Landó, L., Bergman, B. K., Liu, B., Cui, X., & Brown, K. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2107519 · Cited by 2,096 · cited 1×
“Finally, choosing the most appropriate treatment often involves individual characteristics of each patient, and the impact on quality of life can be extremely subjective and difficult to assess.”
BackgroundBlundell, J. E., Baker, J. L., Boyland, E., Blaak, E., Charzewska, J., de Henauw, S., Frühbeck, G., Gonzalez-Gross, M., Hebebrand, J., Holm, L., et al. (2017) · Obesity Facts · doi:10.1159/000455952 · Cited by 1,945
Mingrone, G., Panunzi, S., De Gaetano, A., Guidone, C., Iaconelli, A., Nanni, G., Castagneto, M., Bornstein, S., & Rubino, F. (2015) · The Lancet · doi:10.1016/s0140-6736(15)00075-6 · Cited by 1,220 · cited 11×
“Three studies had data on cholesterol 17,19,20 .”
BackgroundMethodInfluentialBray, G. A., Frühbeck, G., Ryan, D. H., & Wilding, J. P. H. (2016) · The Lancet · doi:10.1016/s0140-6736(16)00271-3 · Cited by 1,036
The Discovery and Development of Liraglutide and Semaglutide
Knudsen, L. B., & Lau, J. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00155 · Cited by 970
Contemporary medical, device, and surgical therapies for obesity in adults
Perdomo, C. M., Cohen, R. V., Sumithran, P., Clément, K., & Frühbeck, G. (2023) · The Lancet · doi:10.1016/s0140-6736(22)02403-5 · Cited by 738 · cited 3×
“In this circum-stance, our findings may not be generalized to patients with obesity without diabetes.”
BackgroundMingrone, G., Panunzi, S., De Gaetano, A., Guidone, C., Iaconelli, A., Capristo, E., Chamseddine, G., Bornstein, S. R., & Rubino, F. (2021) · The Lancet · doi:10.1016/s0140-6736(20)32649-0 · Cited by 577 · cited 10×
“Three studies had data on cholesterol 17,19,20 .”
BackgroundMethodInfluentialSurgery for weight loss in adults
Colquitt, J. L., Pickett, K., Loveman, E., & Frampton, G. K. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003641.pub4 · Cited by 549 · cited 1×
“Finally, choosing the most appropriate treatment often involves individual characteristics of each patient, and the impact on quality of life can be extremely subjective and difficult to assess.”
BackgroundLaparoscopic adjustable gastric banding in the treatment of obesity: A systematic literature review
Chapman, A. (2004) · Surgery · doi:10.1016/s0039-6060(03)00392-1 · Cited by 529
NIH conference. Gastrointestinal surgery for severe obesity. Consensus Development Conference Panel.
(1991) · PubMed · Cited by 496
Steele, C. B., Thomas, C. C., Henley, S. J., Massetti, G. M., Galuska, D. A., Agurs-Collins, T., Puckett, M., & Richardson, L. C. (2017) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6639e1 · Cited by 408
Long-term Outcomes of Laparoscopic Adjustable Gastric Banding
Himpens, J. (2011) · Archives of Surgery · doi:10.1001/archsurg.2011.45 · Cited by 403 · cited 1×
“Finally, choosing the most appropriate treatment often involves individual characteristics of each patient, and the impact on quality of life can be extremely subjective and difficult to assess.”
BackgroundA review of the PubMed PICO tool: using evidence-based practice in health education
Brown, D. (2020) · Health Promotion Practice · doi:10.1177/1524839919893361 · Cited by 367 · cited 1×
“Drafting of the research question was based on the PICO strategy 12 , considering: P (Patients with obesity with indication for bariatric surgery based on BMI); I (Bariatric Surgery); C (Pharmacological treatment); O (Long term morbidity/mortality—at least 5 years of follow up).”
MethodVerrastro, O., Panunzi, S., Castagneto-Gissey, L., De Gaetano, A., Lembo, E., Capristo, E., Guidone, C., Angelini, G., Pennestrì, F., Sessa, L., et al. (2023) · The Lancet · doi:10.1016/s0140-6736(23)00634-7 · Cited by 362 · cited 1×
“Finally, choosing the most appropriate treatment often involves individual characteristics of each patient, and the impact on quality of life can be extremely subjective and difficult to assess.”
BackgroundAbu Dayyeh, B. K., Bazerbachi, F., Vargas, E. J., Sharaiha, R. Z., Thompson, C. C., Thaemert, B. C., Teixeira, A. F., Chapman, C. G., Kumbhari, V., Ujiki, M. B., et al. (2022) · The Lancet · doi:10.1016/s0140-6736(22)01280-6 · Cited by 338 · cited 1×
“Finally, choosing the most appropriate treatment often involves individual characteristics of each patient, and the impact on quality of life can be extremely subjective and difficult to assess.”
BackgroundOrlistat: its current status as an anti-obesity drug
Ballinger, A., & Peikin, S. R. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)01422-x · Cited by 295
Cochrane diagnostic test accuracy reviews
Leeflang, M. M., Deeks, J. J., Takwoingi, Y., & Macaskill, P. (2013) · Systematic Reviews · doi:10.1186/2046-4053-2-82 · Cited by 292 · cited 1×
“As several studies of sufficient quality were available, a meta-analysis was carried out with measures of heterogeneity and publication bias.”
BackgroundIkramuddin, S., Korner, J., Lee, W.-J., Thomas, A. J., Connett, J. E., Bantle, J. P., Leslie, D. B., Wang, Q., Inabnet, W. B., Jeffery, R. W., et al. (2018) · JAMA · doi:10.1001/jama.2017.20813 · Cited by 291
Risk factors for pulmonary embolism
Goldhaber, S. Z., Savage, D. D., Garrison, R. J., Castelli, W. P., Kannel, W. B., McNamara, P. M., Gherardi, G., & Feinleib, M. (1983) · The American Journal of Medicine · doi:10.1016/0002-9343(83)90805-7 · Cited by 246
Phentermine and topiramate for the management of obesity: a review
Uwaifo, G., Cosentino, & Conrad, A. (2013) · Drug Design, Development and Therapy · doi:10.2147/dddt.s31443 · Cited by 242 · cited 1×
“Finally, choosing the most appropriate treatment often involves individual characteristics of each patient, and the impact on quality of life can be extremely subjective and difficult to assess.”
BackgroundRecent Advances in Incretin-Based Pharmacotherapies for the Treatment of Obesity and Diabetes
Tan, Q., Akindehin, S. E., Orsso, C. E., Waldner, R. C., DiMarchi, R. D., Müller, T. D., & Haqq, A. M. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.838410 · Cited by 146
Comprehensive Review of Current and Upcoming Anti-Obesity Drugs
Son, J. W., & Kim, S. (2020) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2020.0258 · Cited by 134
Two‐year effect of semaglutide 2.4 mg on control of eating in adults with overweight/obesity: STEP 5
Wharton, S., Batterham, R. L., Bhatta, M., Buscemi, S., Christensen, L. N., Frias, J. P., Jódar, E., Kandler, K., Rigas, G., Wadden, T. A., et al. (2023) · Obesity · doi:10.1002/oby.23673 · Cited by 124
Phentermine/Topiramate for the Treatment of Obesity
Smith, S. M., Meyer, M., & Trinkley, K. E. (2013) · Annals of Pharmacotherapy · doi:10.1345/aph.1r501 · Cited by 122
Schiavon, C. A., Bhatt, D. L., Ikeoka, D., Santucci, E. V., Santos, R. N., Damiani, L. P., Oliveira, J. D., Machado, R. H. V., Halpern, H., Monteiro, F. L. J., et al. (2020) · Annals of Internal Medicine · doi:10.7326/m19-3781 · Cited by 94 · cited 1×
“Finally, choosing the most appropriate treatment often involves individual characteristics of each patient, and the impact on quality of life can be extremely subjective and difficult to assess.”
BackgroundThe use of sibutramine in the management of obesity and related disorders: An update
Tzotzas, T., Krassas, Tziomalos, K., & Jones, A. (2009) · Vascular Health and Risk Management · doi:10.2147/vhrm.s4027 · Cited by 88
Zhou, Y.-H., Ma, X.-Q., Wu, C., Lu, J., Zhang, S.-S., Guo, J., Wu, S.-Q., Ye, X.-F., Xu, J.-F., & He, J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039062 · Cited by 84 · cited 1×
“Finally, choosing the most appropriate treatment often involves individual characteristics of each patient, and the impact on quality of life can be extremely subjective and difficult to assess.”
BackgroundJärvholm, K., Janson, A., Peltonen, M., Neovius, M., Gronowitz, E., Engström, M., Laurenius, A., Beamish, A. J., Dahlgren, J., Sjögren, L., et al. (2023) · The Lancet Child & Adolescent Health · doi:10.1016/s2352-4642(22)00373-x · Cited by 83 · cited 1×
“Finally, choosing the most appropriate treatment often involves individual characteristics of each patient, and the impact on quality of life can be extremely subjective and difficult to assess.”
BackgroundO’Brien, P. E., Brennan, L., Laurie, C., & Brown, W. (2013) · Obesity Surgery · doi:10.1007/s11695-013-0990-3 · Cited by 69 · cited 4×
“…analysis to estimate the effects of assignment to intervention was not performed 15 ; patients assigned to the control group crossed over to the intervention group, and no measures were reportedly taken to balance that deviation 19 ; there was a significant loss of follow-up for all groups 20 .”
BackgroundMethodInfluentialBoyers, D., Retat, L., Jacobsen, E., Avenell, A., Aveyard, P. N., Corbould, E., Jaccard, A., Cooper, D., Robertson, C., Aceves‐Martins, M., et al. (2021) · International Journal of Obesity · doi:10.1038/s41366-021-00849-8 · Cited by 55
Crawford, M. R., Pham, N. N., Khan, L. A., Bena, J. F., Schauer, P. R., & Kashyap, S. R. (2018) · Endocrine Practice · doi:10.4158/ep-2017-0072 · Cited by 54
Burguera, B. G., Agustí, A. G. N., Arner, P., Baltasar, A., Barbe, F., Barceló, A., Lesmes, I. B., Cabanes, T., Casanueva, F. F., Couce, M., et al. (2007) · Journal of Endocrinological Investigation · doi:10.1007/bf03349226 · Cited by 52 · cited 1×
“Finally, choosing the most appropriate treatment often involves individual characteristics of each patient, and the impact on quality of life can be extremely subjective and difficult to assess.”
BackgroundBjornstad, P., Hughan, K., Kelsey, M. M., Shah, A. S., Lynch, J., Nehus, E., Mitsnefes, M., Jenkins, T., Xu, P., Xie, C., et al. (2020) · Diabetes Care · doi:10.2337/dc19-0708 · Cited by 51 · cited 1×
“Finally, choosing the most appropriate treatment often involves individual characteristics of each patient, and the impact on quality of life can be extremely subjective and difficult to assess.”
BackgroundObesidad y diabetes mellitus tipo 2: también unidas en opciones terapéuticas
Rubio-Almanza, M., Cámara-Gómez, R., & Merino-Torres, J. F. (2018) · Endocrinología Diabetes y Nutrición · doi:10.1016/j.endinu.2018.08.003 · Cited by 46
Ferrulli, A., Macrì, C., Terruzzi, I., Massarini, S., Ambrogi, F., Adamo, M., Milani, V., & Luzi, L. (2019) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13741 · Cited by 45 · cited 1×
“As the purpose of our article is to assess the long-term impact, there are still few articles available that used this drug.”
BackgroundWang, L., Lin, M., Yu, J., Fan, Z., Zhang, S., Lin, Y., Chen, X., & Peng, F. (2021) · Obesity Surgery · doi:10.1007/s11695-021-05671-9 · Cited by 43
Network meta-analysis of metabolic surgery procedures for the treatment of obesity and diabetes
Currie, A. C., Askari, A., Fangueiro, A., & Mahawar, K. (2021) · Obesity Surgery · doi:10.1007/s11695-021-05643-z · Cited by 41
Courcoulas, A. P., Johnson, E., Arterburn, D. E., Haneuse, S., Herrinton, L. J., Fisher, D. P., Li, R. A., Theis, M. K., Liu, L., Taylor, B., et al. (2023) · Annals of Surgery · doi:10.1097/sla.0000000000005155 · Cited by 41 · cited 1×
“Finally, choosing the most appropriate treatment often involves individual characteristics of each patient, and the impact on quality of life can be extremely subjective and difficult to assess.”
BackgroundStenberg, E., & Näslund, E. (2023) · International Journal of Obesity · doi:10.1038/s41366-023-01254-z · Cited by 39 · cited 1×
“Finally, choosing the most appropriate treatment often involves individual characteristics of each patient, and the impact on quality of life can be extremely subjective and difficult to assess.”
BackgroundCotugno, M., Nosso, G., Saldalamacchia, G., Tadini, G. V., Griffo, E., Lupoli, R., Angrisani, L., Riccardi, G., & Capaldo, B. (2014) · Acta Diabetologica · doi:10.1007/s00592-014-0644-5 · Cited by 37 · cited 1×
“Finally, choosing the most appropriate treatment often involves individual characteristics of each patient, and the impact on quality of life can be extremely subjective and difficult to assess.”
BackgroundPEREZ-MONTES DE OCA, A., PELLITERO, S., & PUIG-DOMINGO, M. (2021) · Minerva Endocrinology · doi:10.23736/s2724-6507.20.03369-6 · Cited by 36
Obesity and type 2 diabetes: Also linked in therapeutic options
Rubio-Almanza, M., Cámara-Gómez, R., & Merino-Torres, J. F. (2018) · Endocrinología Diabetes y Nutrición (English ed ) · doi:10.1016/j.endien.2018.11.006 · Cited by 34
Pharmacotherapy of Obesity: Limits and Perspectives
Rosa-Gonçalves, P., & Majerowicz, D. (2019) · American Journal of Cardiovascular Drugs · doi:10.1007/s40256-019-00328-6 · Cited by 34
Nonsurgical weight loss interventions: a systematic review of systematic reviews and meta-analyses
Twells, L. K., Harris Walsh, K., Blackmore, A., Adey, T., Donnan, J., Peddle, J., Ryan, D., Farrell, A., Nguyen, H., Gao, Z., et al. (2021) · Obesity Reviews · doi:10.1111/obr.13320 · Cited by 33 · cited 1×
“Future systematic reviews may reveal a different results when including the new generation of weight loss medication.”
BackgroundUpdike, W. H., Pane, O., Franks, R. B., Saber, F., Abdeen, F., Balazy, D. D., & Carris, N. W. (2021) · Drugs · doi:10.1007/s40265-021-01525-x · Cited by 30 · cited 1×
“More recent studies have also shown that new drugs developed for weight loss may be a viable option for the treatment of this disease 8,9 .”
BackgroundSibutramine: current status as an anti-obesity drug and its future perspectives
Sharma, B., & Henderson, D. C. (2008) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.9.12.2161 · Cited by 30 · cited 1×
“Finally, choosing the most appropriate treatment often involves individual characteristics of each patient, and the impact on quality of life can be extremely subjective and difficult to assess.”
BackgroundHossain, N., Arhi, C., & Borg, C.-M. (2021) · Obesity Surgery · doi:10.1007/s11695-021-05255-7 · Cited by 29 · cited 1×
“Finally, choosing the most appropriate treatment often involves individual characteristics of each patient, and the impact on quality of life can be extremely subjective and difficult to assess.”
BackgroundRecognizing obesity as a disease
Christensen, S. M. (2020) · Journal of the American Association of Nurse Practitioners · doi:10.1097/jxx.0000000000000482 · Cited by 26 · cited 1×
“In addition, many articles do not adequately describe the strategy used in non-surgical treatment.”
BackgroundWilkinson, L., Holst‐Hansen, T., Laursen, P. N., Rinnov, A. R., Batterham, R. L., & Garvey, W. T. (2023) · Obesity · doi:10.1002/oby.23842 · Cited by 25 · cited 1×
“Finally, choosing the most appropriate treatment often involves individual characteristics of each patient, and the impact on quality of life can be extremely subjective and difficult to assess.”
BackgroundCheng, A. K. S., Yeoh, E. C. K., Moh, A. M. C., Low, S. K., Tan, C. H., Lam, B. C. C., Sum, C. F., Subramaniam, T., & Lim, S. C. (2022) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2022.109900 · Cited by 24
Cited by
Moiz, A., Filion, K. B., Tsoukas, M. A., Yu, O. H. Y., Peters, T. M., & Eisenberg, M. J. (2025) · EClinicalMedicine · doi:10.1016/j.eclinm.2025.103363 · Cited by 157
Ndumele, C. E., Rodriguez, F., Dixon, D. L., Khan, S. S., Mukherjee, D., Bajaj, M., Bangalore, S., Bozkurt, B., Breathett, K., Clarke, S. L., et al. (2026) · JACC · doi:10.1016/j.jacc.2026.03.056 · Cited by 90
Ndumele, C. E., Rodríguez, F., Dixon, D. L., Khan, S. S., Mukherjee, D., Bajaj, M. S., Bangalore, S., Bozkurt, B., Breathett, K. K., Clarke, S. L., et al. (2026) · Circulation · doi:10.1161/cir.0000000000001453 · Cited by 160
Brazilian Guidelines of Hypertension – 2025
Brandão, A. A., Rodrigues, C. I. S., Bortolotto, L. A., Armstrong, A. D. C., Mulinari, R. A., Feitosa, A. D. M., Gomes, M. A. M., Barbosa, E. C. D., Moura-Neto, J. A., Neves, M. F., et al. (2025) · Arquivos Brasileiros de Cardiologia · doi:10.36660/abc.20250624 · Cited by 156
Impact of Visceral and Hepatic Fat on Cardiometabolic Health
Khawaja, T., Nied, M., Wilgor, A., & Neeland, I. J. (2024) · Current Cardiology Reports · doi:10.1007/s11886-024-02127-1 · Cited by 49
“…surgical management has been associated with superior long term outcomes for weight reduction and correction of metabolic imbalances; however, emerging evidence and recent pharmacologic advances have the potential to redefine the landscape of personalized medicine and obesity management [38, 39].”
Background
Metadata
- Authors
- Pipek, L. Z., Moraes, W. A. F., Nobetani, R. M., Cortez, V. S., Condi, A. S., Taba, J. V., Nascimento, R. F. V., Suzuki, M. O., do Nascimento, F. S., de Mattos, V. C., Iuamoto, L. R., Hsing, W. T., Carneiro-D’Albuquerque, L. A., Meyer, A., & Andraus, W.
- Affiliations
- Universidade de São Paulo (BR)
- Faculdade de Medicina do ABC (BR)
- Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo (BR)
- Corresponding author
- Meyer, Alberto
- ORCID
- Venue
- Scientific Reports
- Published
- 2024-04-25
- Volume
- 14
- Issue
- 1
- Pages
- 9521-9521
- ISSN
- 2045-2322 (ISSN-L)
- PMC
- PMC11045962
- OpenAlex
- W4395466398
- Cited by
- 80
- References
- 62
- Citations by year
- 2026: 28 · 2025: 46 · 2024: 6
- FWCI
- 8.87
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Scientific Reports (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Surgery › Bariatric Surgery and Outcomes
- Health Sciences › Medicine › Pharmacology (medical) › Pharmacology and Obesity Treatment
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Obesity, Physical Activity, Diet
- Keywords
- obesity, bariatric surgery, pharmacotherapy, weight loss, cardiovascular risk, lipid profile, blood pressure, HbA1c, insulin resistance, long-term outcomes
- MeSH terms
- Humans, Obesity, Weight Loss, Randomized Controlled Trials as Topic, Treatment Outcome, Bariatric Surgery
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.